# Renal Transplantation and Raltegravir in HIV-Infected Patients

> **NCT01453192** · PHASE3 · COMPLETED · sponsor: **ANRS, Emerging Infectious Diseases** · enrollment: 27 (actual)

## Conditions studied

- HIV-1 Infection
- Chronic Renal Insufficiency

## Interventions

- **DRUG:** Raltegravir

## Key facts

- **NCT ID:** NCT01453192
- **Lead sponsor:** ANRS, Emerging Infectious Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01453192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01453192, "Renal Transplantation and Raltegravir in HIV-Infected Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01453192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*